Health Trials

Early Relapses of Acute Myeloid Leukemia

1

Review clinical trials related to Early Relapses of Acute Myeloid Leukemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML

The primary objective is to evaluate the efficacy and toxicity of high versus low intensity therapy options in patients with refractory forms and early relapses of acute myeloid leukemia (R/R AML) who are scheduled for allogeneic hematopoietic stem cell transplantation (alloHSCT).

Participants needed: 198
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: National Research Center for Hematology, RussiaUpdated: May 17, 2024Locations: 1
Eligibility criteria

Age ≥ 18 years; [+3]

Late relapsed AML; [+23]

Read more